Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Melco Resorts & Entertainment ADR | MLCO | Mar 13, 2025 | 5.45 | -0.37 |
MercadoLibre | MELI | Mar 13, 2025 | 1 989.70 | -0.75 |
Mercantile Bank | MBWM | Mar 13, 2025 | 43.67 | -1.13 |
Mercer International | MERC | Mar 13, 2025 | 6.16 | -2.99 |
Merchants Bancorp | MBIN | Mar 13, 2025 | 36.63 | +0.08 |
Merchants Bancorp C Pref | MBINN | Mar 13, 2025 | 21.76 | 0.00 |
Merchants Bancorp Pref D | MBINM | Mar 13, 2025 | 25.89 | +0.15 |
Merck & Co | MRK | Mar 13, 2025 | 94.71 | +1.46 |
Mercurity Fintech | MFH | Mar 13, 2025 | 4.86 | +1.46 |
Mercury General | MCY | Mar 13, 2025 | 55.48 | +1.20 |
Mercury Systems | MRCY | Mar 13, 2025 | 45.08 | +7.08 |
Mereo BioPharma ADR | MREO | Mar 13, 2025 | 2.50 | -1.57 |
Meridian | MRBK | Mar 13, 2025 | 13.77 | -0.94 |
MeridianLink | MLNK | Mar 13, 2025 | 19.24 | -2.14 |
Merit Medical Systems | MMSI | Mar 13, 2025 | 97.66 | -0.72 |
Meritage Homes | MTH | Mar 13, 2025 | 69.41 | -3.81 |
Merrill Lynch & Co. | IPB | Mar 13, 2025 | 25.66 | +0.61 |
Mersana Therapeutics | MRSN | Mar 13, 2025 | 0.45 | -12.19 |
Merus N.V | MRUS | Mar 13, 2025 | 47.64 | -3.09 |
Mesa Air Group | MESA | Mar 13, 2025 | 0.91 | -2.90 |
Mesa Laboratories | MLAB | Mar 13, 2025 | 122.33 | -0.88 |
Mesa Royalty Trust | MTR | Mar 13, 2025 | 6.27 | -0.31 |
Mesabi Royalty Trust | MSB | Mar 13, 2025 | 25.65 | +0.12 |
Mesoblast ADR | MESO | Mar 13, 2025 | 13.28 | -1.26 |
Meta Platforms A | META | Mar 13, 2025 | 590.64 | -4.67 |
Metagenomi | MGX | Mar 13, 2025 | 1.91 | -6.83 |
Metal Sky Star Acquisition | MSSA | Mar 13, 2025 | 12.00 | 0.00 |
Metalla Royalty & Streaming | MTA | Mar 13, 2025 | 2.92 | +1.74 |
Metallus | MTUS | Mar 13, 2025 | 13.35 | +0.15 |
MetaVia | MTVA | Mar 13, 2025 | 1.50 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.